ACE2 and COVID-19: Direct myocardial injury, inflammation and thrombosis, hypoxemia, and ACE2 downregulation are suggested to be involved in COVID-19-mediated cardiac pathology; however, the pathogenic mechanisms underlying the increased vulnerability to heart failure in patients with COVID-19 are still largely unknown [9–11].